Advancing Bispecifics for Combination Immunotherapy
PharmaTalkRadio2 Maalis 2020

Advancing Bispecifics for Combination Immunotherapy

First recorded at the fourth annual IO Combinations 360° conference, this panel moderated by Dr Daniel Chen, IGM Biosciences discusses advancing bispecifics for combination immunotherapy. This discussion covers the following topics: What are the types of bispecifics and what are the limitations?What are the toxicity related side effects?What are teh next steps/levels for bispecifics?What does the future hold for bispecifics? Panelists include: Julie Bailis, PhD, AmgenRajkumar Ganesan, PhD, Janssen Research & DevelopmentDavid Schaer, PhD, Pfizer To learn more about the 5th annual IO Combinations 360° conference please visit www.iocombinations360.com

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(461)

Suosittua kategoriassa Tiede

utelias-mieli
tiedekulma-podcast
rss-mita-tulisi-tietaa
rss-hereilla
rss-duodecim-lehti
rss-poliisin-mieli
rss-totuuden-liepeilla
rss-kasvatuspsykologiaa-kaikille
rss-tiedetta-vai-tarinaa
koodikahvit
docemilia
rss-ja-ihminen-loi-alyn-aalto-yliopiston-tekoalypodcast